Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Rooftop Centers 2021-2026 (Dps)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V (Open House Model)

Open House Contracts for Multiple Active Ingredients

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Dabigatran Etexilate (Atc Code: B01ae07).

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Nilotinib (Atc Code: L01ea03).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (Atc Code: R03al08).

Dynamic Procurement System of the Public Administration for the Supply of Health Goods and Services. Id 2676

Dynamic Procurement System of the Public Administration for the Acquisition of Pharmaceutical Products. Id 2677

Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Amifampridine (Atc Code According to Who: N07xx05)